Influenza A virus vaccine H5N1 intranasal - BioDiem

Drug Profile

Influenza A virus vaccine H5N1 intranasal - BioDiem

Alternative Names: Avian (H5N1) intranasal influenza virus vaccine - BioDiem; Intranasal H5N1 influenza virus vaccine - BioDiem/Centers for Disease Control and Prevention

Latest Information Update: 28 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
  • Developer BioDiem; Centers for Disease Control and Prevention
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H5N1 subtype

Most Recent Events

  • 28 Jan 2018 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype in Russia (Intranasal)
  • 28 Jan 2018 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype in Thailand (Intranasal)
  • 28 Jan 2018 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top